Welcome to our dedicated page for Gohealth SEC filings (Ticker: GOCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The GoHealth, Inc. (NASDAQ: GOCO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. As a health insurance marketplace and Medicare-focused digital health company, GoHealth uses its filings to report financial results, capital structure changes, governance updates, and key operating metrics.
Core documents for GOCO include annual reports on Form 10-K and quarterly reports on Form 10-Q, where the company discusses its Medicare-focused marketplace model, non-GAAP measures such as EBITDA and Adjusted EBITDA, and operating metrics like Submissions, Sales per Submission, Direct Operating Cost of Submission, and Direct Operating Cost per Submission. These filings also contain sections such as “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which elaborate on the environment in which GoHealth operates.
GoHealth’s current reports on Form 8-K provide timely detail on material events. Recent 8-K filings describe the announcement of quarterly results, the entry into a superpriority senior secured term loan facility, amendments to the existing credit agreement, the issuance of Class A common stock to lenders, and changes in the composition of the board of directors, including the creation of a Transformation Committee. Other 8-Ks report annual meeting voting results and director appointments or resignations.
On this page, Stock Titan’s AI features summarize lengthy filings so users can quickly see what changed in each document, such as new financing terms, covenant adjustments, or governance provisions. Real-time updates from EDGAR ensure that newly filed 10-Ks, 10-Qs, and 8-Ks for GOCO appear promptly, while AI-generated highlights help explain complex credit agreement amendments, liquidity covenants, and board-level decisions.
For those examining GoHealth’s regulatory history, this filings page offers structured access to its SEC reports, including details on financial performance, capital structure, and corporate governance, supported by automated summaries that make dense legal and financial language easier to understand.
Mark Robert Weinstein, listed at the Chicago address on the form, filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to GoHealth, Inc. (GOCO) as a Director. The event date shown is 08/19/2025. The filing states no securities are beneficially owned and notes the Form was submitted late due to delays obtaining the reporting person’s EDGAR codes. The filing includes Exhibit 24 (Power of Attorney) and is signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025. The filing was made by one reporting person.
Form 3 filed for GoHealth, Inc. (GOCO) reports that Truong Bao Dinh, identified as a Director, had no securities beneficially owned as of the event date 08/19/2025. The form is an initial ownership disclosure and was signed on 08/28/2025 by an attorney-in-fact. The filing lists a Power of Attorney as Exhibit 24 and contains no holdings or derivative positions to report.
GoHealth, Inc. reported several changes to its Board of Directors. On August 19, 2025, the Board appointed Mark Weinsten as a Class II director, with a term running until the 2028 annual stockholders’ meeting. He is a managing director in BRG Corporate Finance and will receive a monthly cash retainer of $25,000, pro-rated for his first partial month, plus reimbursement of certain expenses.
The Board also appointed Bao Truong, a senior managing director at Centerbridge Partners, L.P., as a Class III director with a term expiring at the 2026 annual stockholders’ meeting. He joined the Transformation Committee, Compensation Committee, and Nominating and Corporate Governance Committee and, as a Centerbridge employee, will not receive Board compensation. Both new directors entered into GoHealth’s standard director indemnification agreements, and each was nominated as a Centerbridge designee under a 2020 Stockholders Agreement.
On the same date, Centerbridge designees Jeremy W. Gelber and Abhiraj Modi resigned from the Board. The company stated their resignations did not result from any disagreement regarding operations, policies, or practices.
Public Sector Pension Investment Board (PSP) filed an Initial Statement of Beneficial Ownership reporting indirect beneficial ownership of 1,680,526 shares of GoHealth, Inc. (GOCO) Class A common stock. The filing identifies PSP USA, a wholly owned PSP subsidiary, as holding 1,680,444 shares directly and an additional 82 shares through a fund-of-one, which PSP may be deemed to indirectly own. The event requiring the statement is dated 08/06/2025 and the form is signed by Martine Vanasse, MD & Chief Compliance Officer on 08/15/2025. The filer is identified as a Director relationship to the issuer and the filing is an initial Form 3 disclosure.
GoHealth, Inc. issued Class A Common Stock to lenders as part of an amendment to its credit agreement, and two related reporting persons filed a joint Schedule 13D disclosing their holdings. The Public Sector Pension Investment Board (PSP) reports beneficial ownership of 1,680,526 shares (reported as 10.5% of the class). PSP Investments Credit USA LLC reports beneficial ownership of 1,680,444 shares (reported as 10.5% of the class).
The percentage figures are calculated using an outstanding base of 11,222,135 shares as of August 5, 2025, plus 4,766,219 shares issued on August 6, 2025. The shares were issued to lenders, including PSP USA, as consideration and a condition to the lenders’ entry into Amendment No. 14 to the existing credit agreement. The filing states no other transactions in the past 60 days by the reporting persons and discloses no criminal or securities-related judgments for the reporting persons or their scheduled officers.
GoHealth, Inc. amended its existing credit agreement (Amendment No. 14) on August 6, 2025 as part of refinancing activity and issued shares of its Class A common stock to lenders and their affiliates as consideration for the amendment. Among those recipients, the Redwood Funds and related reporting entities received an aggregate of 924,244 shares of Class A common stock, which the filing states represents 5.8% of the Class A stock based on 11,222,135 shares outstanding as of August 5, 2025 plus 4,766,219 shares issued on August 6, 2025.
The filing shows the Reporting Persons have shared voting and shared dispositive power over the 924,244 shares and report no sole voting or dispositive power. The issuance to lenders is described solely as consideration for the credit agreement amendment; no other transactions in the past 60 days are reported.
Public Sector Pension Investment Board (PSP) and its subsidiary PSP Investments Credit USA LLC acquired a material equity stake in GoHealth, Inc. The Reporting Persons received shares of GoHealth Class A common stock as consideration tied to an amendment of the Issuer's existing credit agreement, with shares issued to lenders and their affiliates, including PSP USA.
The filing reports beneficial ownership of 1,680,526 shares (PSP) and 1,680,444 shares (PSP USA), each representing 10.5% of the Class A stock on the filing’s stated basis. The ownership percentage is calculated using 11,222,135 shares outstanding as of August 5, 2025 plus 4,766,219 shares issued on August 6, 2025, per the issuer’s disclosure. The Schedule 13D discloses no other transactions in the prior 60 days and attaches a joint filing agreement and a list of PSP executives and directors as exhibits.
GoHealth reported mixed results for the quarter ended June 30, 2025. Net revenues declined to $94.0 million from $105.9 million a year earlier, while year-to-date revenues increased to $315.0 million from $291.5 million. The company recorded a significant $53.0 million indefinite-lived trade names impairment that, together with higher operating expenses, drove an operating loss of $99.4 million for the quarter and a net loss attributable to GoHealth of $54.3 million (basic loss per Class A share $5.10).
Liquidity and capital structure changed materially: cash and cash equivalents were $35.6 million, total long-term debt rose to $560.0 million and commissions receivable remained substantial at $996.6 million. Management states that after entering a Superpriority Credit Agreement and amendments, management believes available liquidity is sufficient to cover operating requirements for the next 12 months, alleviating prior substantial doubt about going concern.
Blue Torch Capital LP and Kevin Genda report beneficial ownership of 1,445,181 shares of GoHealth, Inc. Class A common stock, representing 9% of the class. The filing states these shares were issued to lenders and their affiliates as consideration and a condition to lender participation in Amendment No.14 to the Issuer's Credit Agreement dated August 6, 2025. The Reporting Persons disclose shared voting and shared dispositive power over these shares and report no sole voting or dispositive power.
The statement identifies Blue Torch as an investment manager and Mr. Genda as the managing member of the general partner. The percentage calculation references 11,222,135 shares outstanding as of August 5, 2025 plus 4,766,219 shares issued on August 6, 2025. No other transactions in the past 60 days are reported.
Amendment No. 5 to the Schedule 13D discloses a Superpriority Senior Secured Term Loan package totaling $115.0 million for Norvax, LLC, comprised of $80.0 million new-money term loans (with $40.0 million funded immediately and $40.0 million as delayed-draw availability) and $35.0 million of roll-up term loans from conversion of existing Class A revolving loans.
The related amendment to the existing credit agreement terminates Class A-1 and Class A revolving commitments, extends the maturity of remaining Class A revolving loans to August 5, 2029, permits pay-in-kind interest with an accrual rate of Adjusted Term SOFR + 8.00% (with at least Adjusted Term SOFR + 4.50% paid in cash), and waives amortization of existing term loans until December 31, 2026. As consideration, the issuer issued 4,766,219 Class A shares to certain lenders, representing 19.99% of the combined issued and outstanding Class A and Class B common stock, with customary registration rights. The Board appointed three new directors and three existing directors resigned.
Reporting Persons disclose beneficial ownership stakes in Class A common stock: CCP III Cayman GP Ltd. 9,566,028 shares (45.0%), CB Blizzard Holdings C 1,467,653 shares (9.2%), Centerbridge Associates III, L.P. and related entities 2,712,197 shares (17.1%), Blizzard Aggregator, LLC 5,386,178 shares (25.3%), and Jeffrey H. Aronson 9,566,028 shares (45.0%). The filing states the group may be deemed to collectively beneficially own 16,007,486 shares, approximately 58.3% of 15,881,344 reported Class A shares outstanding.